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Abstract 
Mantle cell lymphoma represents 2.5-7% all
of non Hodgkin’s lymphomas. Stomach is the
most common site of extranodal lymphoma.
However, that is not the case with mantle cell
lymphoma, which is extremely rare. We pres-
ent a case of 71-year-old woman admitted to
the Internal Clinic of the University Clinical
Hospital Center Rijeka, because of stomach
discomfort and melena. Endoscopy and com-
puted tomography revealed a polyp in gastric
antrum. Histopathologic, immunohistochemic
and genetic methods were also performed and
the results were consistent with primary gas-
tric mantle cell lymphoma without periepigas-
tric and/or local or distant abdominal lymph
node involvement.
Introduction
Primary isolated gastric mantle cell lym-
phoma (MCL) is an extremely rare form of gas-
trointestinal tumour. It represents 2.5-7%1 of
all non-Hodgkin’s lymphomas. However, stom-
ach is the most comon site of extranodal lym-
phoma, which are almost all of B-cell lineage,
including extranodal marginal zone B-cell lym-
phomas of mucosa-associated lymphoid tissue
(MALT lymphoma) and diffuse large B-cell lym-
phomas (DLBC).2,3 Development of MCL is a
result of malignant transformation of B-cell
lymphocytes in mantle zone of a lymph node
follicle - pregerminal center that surrounds
normal germinal center follicles. This subtype
of non-Hodkin’s lymphoma is also caracterized
by the chromosomal translocation t(11;14)
(q13;q32).3,4 Specific result of this transloca-
tion is an overexpression of the cyclin D1
(CCND1), which is normally not expressed in
B lymphocytes, who have a very important rolle
in cell cycle regulation. Furthermore, immuno-
histochemical phenotype CD5+, CD19+,
CD20+, CD10-, CD23-, FMC-7+, bcl-2+ and
cyclin D1+ is specific of MCL.2-6 We however
need to emphasize that aberrant immunophe-
notype was also established in several
cases.4,7-8 Although nowadays we do have pow-
erful genetic, immunohistocemical and other
modern diagnostic and therapeutic methods,
MCL still presents itself as a very aggressive
disease with poor prognosis and median sur-
vival of 3-4 years.1
The first case of isolated primary MCL has
been published in 2004.9 Since then very few
case reports have been reported and published,
and those that were usually were secondary
gastric involvements from nodal mantle cell
lymphoma (MCL) or lymphomas in the course
of primary intestinal MCL (lymphomatous
polyposis). 
We present a case of gastric MCL in a patient
without other gastrointestinal comorbidities
and without personal history of significant ill-
nessess (except mild arterial hypertension).
Case Report
A 71-year-old, previously healthy female
patient was admitted at the Internal Clinic of
the University Clinical Hospital Center Rijeka,
because of persistent stomach discomfort
(lasting for 5 months) and melena. Her med-
ical records showed that she had been previ-
ously diagnosed only with mild arterial hyper-
tension and had no gastrointestinal symptoms.
Physical examination revealed an overweight,
pale, cardiorespiratory compensated patient
without any palpable peripheral lymph nodes,
no liver or spleen enlargement or any patholog-
ic abdominal mass. However, the patient com-
plained of slight discomfort during the palpa-
tion of the epigastric region.
Laboratory analyses showed anemia due to
iron deficiency (Hemoglobin 94 g/L, MCV 81 fL,
MCHC 318 g/L, Fe 3 umol/L, UIBC 62 umol/L,
feritin 16 ug/L), with slightly elevated ESR (38
mm/h). Leukocyte total count was normal (4,2
¥109/L) with proportional leukocyte differen-
tial count. Platelets (357¥109/L) and coagula-
tion tests were in normal range as well as
other biochemical analyses (proteinogram,
CRP and LDH). 
Gastroscopy (Figure 1) and computerized
tomography (Figure 2) identified a large ulcer-
ated tumor with polypoid surface in the gastric
antrum, with no apparent local lymph node
involvement. 
Histological analysis of tissue taken by gas-
tric biopsy revealed a dense atypical lymphoid
infiltrate composed of small to medium sized
cells with slightly irregular nuclear contours.
Immunohistochemically, cells were positive for
CD20, CD5, CD79a, CD43 and cyclin D1, but
negative for CD3, and bcl-6 (Figure 3). 
Fluorescent in situ hybridization studies
showed the presence of the chromosomal
translocation t(11;14)(q13;q32), which is
characteristic for MCL. Extensive clinical
staging was performed but no further evi-
dence of lymphoma was established
(colonoscopy; computerized tomography of
thorax, abdomen and pelvis; bone marrow
analysis). Following chemotherapy (8 cycle R-
CHOP) the patient is disease free at 12
months after diagnosis, confirmed by PET/CT
immaging and gastroscopy.
Discussion
We present a case where MCL is not associ-
ated with any other gastrointestinal patholog-
ical condition. However, we took into consid-
eration comorbidities often associated with
appearance of MCL. MCL is more likely to
appear along with other gastrointestinal dis-
eases (Chron’s disease, adenocarcinoma).1,2,9
In the vast majority of cases, gastrointestinal
lymphoma can be diagnosed with endoscopic
biopsy. By using additional immunological and
molecular markers we can group lymphomas
into subtypes according to the WHO classifica-
tion and that is the cornerstone for further
decision making. We retrospectively reviewed
clinical features, including involved organs,
histopathologic examination, immunohisto-
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chemic and genetic methods. We also estab-
lished Cyclin D1 overexpression and per-
formed immunohistochemic methods (cells
were positive for CD20, CD5, CD79a, CD43
and negative for CD3) which finally confir-
mated the diagnosis of gastric MCL.
Primary gastrointestinal mantle cell lym-
phomas are very uncommon and they rarely
involve stomach. Contrary to that, stomach is
the most common site of primary extranodal
lymphoma, although almost all cases are of B-
cell lineage. Isolated primary gastric localiza-
tion is extremely rare. All that being said, man-
tle cell lymphoma is a specific type of malig-
nant lymphoma that has been reported mostly
through case reports.1,9 Therefore, the fact that
there are only few reported cases limits our
understanding of primary mantle cell lym-
phoma from a clinical and therapeutic view-
point. 
Treatment of MCL is nowhere near satisfac-
tory and there are no proven and standard
regimes used in therapy. Standard therapy by
alkylating agents (with or without corticos-
teroids) offers substantial palliation but no
real cure and treatment therefore fails in
majority of cases. Effective treatment of gastric
MCL still remains a very controversial issue
with very poor response rates.10-12
Conclusions
Primary isolated gastric mantle cell lym-
phoma (MCL) is an extremely rare form of gas-
trointestinal tumour. Stomach is the most
common site of extranodal lymphoma. To our
knowledge, only few authors described the
appearance of a primary gastric mantle cell
lymphoma. However, in those cases tumor
occurence was associated with other gastroin-
testinal diseases. Therefore, the fact that there
are only few reported cases limits our under-
standing of primary mantle cell lymphoma
from a clinical and therapeutic viewpoint. We
present a case where MCL was not associated
with any other gastrointestinal pathological
condition, even though Chron’s disease and
adenocarcinoma were taken into considera-
tion. Current experiences with treatment of
MCL are very poor and there are no proven and
standard regimes used in therapy. Effective
treatment of gastric MCL still remains a very
controversial issue with very poor response
rates. Therefore, mantle cell lymphoma has a
very poor prognosis. In the light of everything
said, one should always consider a primary
mantle cell lymphoma if a solitary gastroin-
testinal polypoid tumor is discovered, especial-
ly if no other gastrointestinal diseases are
present.
Case Report
Figure 1. Gastroscopy - tumor presence in
the gastric antrum.
Figure 2. Computerized tomography.
Diffuse wall thickening of the gastric
antrum, which is in direct contact with the
wall of duodenum and suppresses pan-
creas.
Figure 3. Histological picture of gastric mantle-cell lymphom. Magnification x 40. A)
tumor cells show nodular and diffuse infiltration of gastric mucosa; B), C) and D) tumor
cells are positive for CD20, ciklinD1 and CD5 antigen; E) and F) tumor cells are negative
for CD3 and bcl-6. 
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